GMRAX
Price
$11.09
Change
+$0.18 (+1.65%)
Updated
Jun 3 closing price
Net Assets
214.4M
VSMAX
Price
$110.66
Change
+$1.45 (+1.33%)
Updated
Jun 3 closing price
Net Assets
139.54B
Interact to see
Advertisement

GMRAX vs VSMAX

Header iconGMRAX vs VSMAX Comparison
Open Charts GMRAX vs VSMAXBanner chart's image
Nationwide Small Cap Index A
Price$11.09
Change+$0.18 (+1.65%)
VolumeN/A
Net Assets214.4M
Vanguard Small Cap Index Admiral Shares
Price$110.66
Change+$1.45 (+1.33%)
VolumeN/A
Net Assets139.54B
GMRAX vs VSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GMRAX vs. VSMAX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMRAX is a Buy and VSMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 140B vs. GMRAX (214M). VSMAX (1.48) and GMRAX (1.45) have matching dividends . GMRAX was incepted earlier than VSMAX: GMRAX (25 years) vs VSMAX (25 years). GMRAX (0.72) is less costly to investors than VSMAX (0.05). GMRAX is a more actively managed with annual turnover of: 15.50 vs. VSMAX (13.00). GMRAX has a lower initial minimum investment than VSMAX: GMRAX (2000) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 3.59 vs. GMRAX (-2.29). VSMAX return over 5 years is better than : 55.35 vs. GMRAX (32.09).
GMRAXVSMAXGMRAX / VSMAX
Total Expense Ratio0.680.051,360%
Annual Report Gross Expense Ratio0.720.051,440%
Fund Existence25 years25 years-
Gain YTD-6.911-5.077136%
Front Load6%N/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets214M140B0%
Annual Yield % from dividends1.451.4898%
Returns for 1 year-2.293.59-64%
Returns for 3 years7.4617.4943%
Returns for 5 years32.0955.3558%
Returns for 10 years-25.7192.75-28%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK10.900.99
+9.99%
Stoke Therapeutics
FORM31.361.34
+4.46%
FormFactor
BDRX1.160.01
+0.87%
Biodexa Pharmaceuticals plc
CATO2.59N/A
N/A
CATO Corp
NTRA160.15-0.54
-0.34%
Natera